Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Toxicity of a Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma

NCT02264379 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT02264379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02264379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Toxicity of a Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma
Lead sponsor
Technische Universität Dresden
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
August 31, 2021
Enrollment
73 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic disease, prostate cancer